GADD45G Antikörper (AA 96-109)
Kurzübersicht für GADD45G Antikörper (AA 96-109) (ABIN1886724)
Target
Alle GADD45G Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 96-109
-
Aufreinigung
- Purified by antigen-affinity chromatography.
-
Immunogen
- Synthetic peptide contain a sequence corresponding to a region within amino acids 96 and 109 (O95257) of GADD45G
-
-
-
-
Applikationshinweise
-
Suggested dilutions:
Western blotting: 1.500-1.3000
Immunofluorescence: 1.100-1.200 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- 0.1 M Tris-buffered saline with 10 % Glycerol (pH 7.0).0.01 % Thimerosal was added as a preservative.
-
Konservierungsmittel
- Thimerosal (Merthiolate)
-
Vorsichtsmaßnahmen
- Biohazard Informations: This product contains thimerosal which is hazardous.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
-
-
- GADD45G (Growth Arrest and DNA-Damage-Inducible, gamma (GADD45G))
-
Andere Bezeichnung
- GADD 45 gamma
-
Hintergrund
-
This gene is a member of a group of genes whose transcript levels are increased following stressful growth arrest conditions and treatment with DNA-damaging agents.The protein encoded by this gene responds to environmental stresses by mediating activation of the p38/JNK pathway via MTK1/MEKK4 kinase.The GADD45G is highly expressed in placenta.[provided by RefSeq]
Synonyms: CR6, DDIT2, GRP17, GADD45gamma -
Molekulargewicht
- 17 kDa
-
Gen-ID
- 10912
-
NCBI Accession
- NP_006696, NM_006705
-
Pathways
- Zellzyklus
Target
-